13 November

UMB-born Breethe technology gets FDA clearance

Published 11/10/20 in Technical.ly Baltimore Developed by a University of Maryland School of Medicine surgeon, Breethe was acquired in May by Massachusetts medical device company Abiomed. The company says it could help COVID-19 patients. An acquisition wasn’t the only milestone …

02 November

Innovations in Health care

https://www.jmoreliving.com/wp-content/uploads/2020/10/2020_10_Jmore.pdf See complete article “Innovations in Health care | Salute to the medical and scientific trailblazers” — Pages 37-42 Published 10/2020 in JMore Living

15 September

UM Ventures’ GlycoT Therapeutics grants technology sublicense to Daiichi Sankyo

Published in the Daily Record, 9/14/20 GlycoT Therapeutics LLC, a UM Ventures startup company based on intellectual property developed at the University of Maryland, Baltimore and University of Maryland, College Park, executed a sublicense agreement for its glycoengineering technology with Daiichi Sankyo Company, Limited, GlycoT officials said …